Rapport Therapeutics Inc
RAPPHealthcare|Biotechnology|USA
$41.79
-0.25 (-0.60%)
Tangible Book
$9.86
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (41)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gault Cheryl | COO | 2026-06-30 | SELL | 10,000 | $41.58 | $415.8K |
| Ceesay Abraham | CEO | 2026-06-29 | SELL | 8,220 | $39.83 | $327.4K |
| Third Rock Ventures V, L.P. | 10% Owner | 2026-05-26 | SELL | 18,572 | $40.05 | $743.8K |
| Third Rock Ventures V, L.P. | 10% Owner | 2026-05-11 | SELL | 133,618 | $40.24 | $5376.8K |
| Third Rock Ventures V, L.P. | 10% Owner | 2026-05-08 | SELL | 276,513 | $40.12 | $11093.7K |
| Third Rock Ventures V, L.P. | 10% Owner | 2026-04-17 | SELL | 426,005 | $40.32 | $17176.5K |
| Yeleswaram Krishnaswamy | Chief Development Officer | 2026-04-17 | SELL | 20,225 | $39.99 | $808.8K |
| Yeleswaram Krishnaswamy | Chief Development Officer | 2026-04-14 | SELL | 19,865 | $35.03 | $695.9K |
| Yeleswaram Krishnaswamy | Chief Development Officer | 2026-04-08 | SELL | 360 | $34.9 | $12.6K |
| Gault Cheryl | COO | 2026-03-30 | SELL | 10,000 | $28.19 | $281.9K |
| Yeleswaram Krishnaswamy | Chief Development Officer | 2026-03-25 | SELL | 10,115 | $29.99 | $303.3K |
| Gault Cheryl | COO | 2026-03-05 | SELL | 2,014 | $28.93 | $58.3K |
| Ceesay Abraham | CEO | 2026-02-18 | SELL | 10,916 | $29.35 | $320.4K |
| Bredt David | Chief Scientific Officer | 2026-02-17 | SELL | 8,500 | $29.02 | $246.7K |
| Ceesay Abraham | CEO | 2026-01-20 | SELL | 10,916 | $26.11 | $285K |
| Bredt David | Chief Scientific Officer | 2026-01-15 | SELL | 8,500 | $26.84 | $228.1K |
| Bredt David | Chief Scientific Officer | 2025-12-31 | SELL | 6,567 | $30.05 | $197.3K |
| Yeleswaram Krishnaswamy | Chief Development Officer | 2025-12-31 | SELL | 2,840 | $30.05 | $85.3K |
| Ceesay Abraham | CEO | 2025-12-17 | SELL | 10,916 | $29.64 | $323.6K |
| Bredt David | Chief Scientific Officer | 2025-12-15 | SELL | 8,500 | $30.02 | $255.2K |
| Gault Cheryl | COO | 2025-11-26 | SELL | 5,000 | $30.1 | $150.5K |
| Ceesay Abraham | CEO | 2025-11-17 | SELL | 10,916 | $25.2 | $275.1K |
| Bredt David | Chief Scientific Officer | 2025-11-17 | SELL | 8,500 | $25.19 | $214.1K |
| Bredt David | Chief Scientific Officer | 2025-10-15 | SELL | 8,500 | $25.79 | $219.2K |
| Ceesay Abraham | CEO | 2025-10-15 | SELL | 10,916 | $25.81 | $281.7K |
| Ceesay Abraham | CEO | 2025-09-17 | SELL | 76,420 | $26.32 | $2011.4K |
| Bredt David | Chief Scientific Officer | 2025-09-15 | SELL | 8,500 | $24.19 | $205.6K |
| Huber Reid M | Director | 2025-09-12 | BUY | 20,400 | $24.48 | $499.4K |
| PAUL STEVEN M | Director | 2025-09-12 | BUY | 41,666 | $24.65 | $1027.1K |
| Young Wendy B. | Director | 2025-09-11 | BUY | 3,500 | $22.6 | $79.1K |
| Gault Cheryl | COO | 2025-09-08 | SELL | 5,000 | $38.33 | $191.7K |
| Bredt David | Chief Scientific Officer | 2025-08-15 | SELL | 8,500 | $15 | $127.5K |
| Bredt David | Chief Scientific Officer | 2025-07-15 | SELL | 8,500 | $14 | $119K |
| Bredt David | Chief Scientific Officer | 2025-06-16 | SELL | 8,500 | $11 | $93.5K |
| Bredt David | Chief Scientific Officer | 2025-05-15 | SELL | 8,500 | $9.56 | $81.3K |
| Bredt David | Chief Scientific Officer | 2025-04-15 | SELL | 8,500 | $9.57 | $81.3K |
| Bredt David | Chief Scientific Officer | 2025-03-14 | SELL | 8,500 | $10.85 | $92.2K |
| Ignelzi Troy A. | CFO | 2025-03-13 | BUY | 10,000 | $10.1 | $101K |
| Young Wendy B. | Director | 2025-03-12 | BUY | 6,000 | $10.21 | $61.3K |
| HEALY JAMES | Director | 2024-07-01 | BUY | 44,032 | $24.52 | $1079.7K |
| HEALY JAMES | Director | 2024-06-10 | BUY | 558,824 | $17 | $9500K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked